Physician profile
Joyce E Patouhas
NPI 1598794489
$2,530.31
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $59.40 · 2021: $1,017 · 2022: $1,052 · 2023: $15.21 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,865.21 | 2021-2023 | Phantom Metatarsal Shortening |
| Cardiovascular Systems INC. | $134.92 | 2019 | |
| Horizon Therapeutics Plc | $133.33 | 2019-2021 | |
| Kerecis Limited | $97.78 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $86.10 | 2021 | |
| Misonix INC | $53.45 | 2021 | |
| Medtronic, INC. | $28.51 | 2022-2025 | Inceptiv |
| Melinta Therapeutics, LLC | $28.25 | 2019 | |
| Wright Medical Technology, INC. | $23.15 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.83 | 2022 | |
| Linvatec Corporation | $13.88 | 2022 | |
| Amgen INC. | $13.79 | 2025 | Krystexxa |
| Heron Therapeutics, INC. | $11.97 | 2021 | |
| Smith+Nephew, INC. | $11.92 | 2019 | |
| Organogenesis INC. | $6.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Patouhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.